Table 3.
Variable | Tai Chi Group (N = 33) | Control Group (N = 33) | P Value* |
---|---|---|---|
no. of patients (%) | |||
FIQ score† | |||
Week 12 | 26 (78.8) | 13 (39.4) | 0.001 |
Week 24 | 27 (81.8) | 17 (51.5) | 0.009 |
Patient’s global assessment‡ | |||
Week 12 | 18 (54.5) | 9 (27.3) | 0.02 |
Week 24 | 18 (54.5) | 9 (27.3) | 0.02 |
PSQI score§ | |||
Week 12 | 13 (39.4) | 4 (12.1) | 0.01 |
Week 24 | 15 (45.5) | 6 (18.2) | 0.02 |
CES-D score¶ | |||
Week 12 | 24 (72.7) | 16 (48.5) | 0.04 |
Week 24 | 23 (69.7) | 13 (39.4) | 0.01 |
SF-36 scores|| | |||
Physical component | |||
Week 12 | 18 (54.5) | 5 (15.2) | 0.001 |
Week 24 | 17 (51.5) | 5 (15.2) | 0.002 |
Mental component | |||
Week 12 | 14 (42.4) | 8 (24.2) | 0.12 |
Week 24 | 16 (48.5) | 8 (24.2) | 0.04 |
P values were calculated with the use of the chi-square test.
A change in the score on the Fibromyalgia Impact Questionnaire (FIQ) of 14% (or 8.1 units) indicates clinically meaningful improvement.30
A reduction of 30% (or 2 points) on a visual-analogue scale indicates clinically meaningful improvement.31
A change of greater than 5 in the total score of the Pittsburgh Sleep Quality Index (PSQI) indicates clinically meaningful disturbed or poor sleep.24
A reduction of 10% (or 6 points) on the Center for Epidemiologic Studies Depression (CES-D) index indicates a clinically significant change.32